Cabaletta Bio, Inc. (CABA) stock
CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.01−0.04 (-4.27%)
Close on Nov 19, 2026Market cap $171.24MP/E –Yield –
Cabaletta Bio shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Cabaletta Bio's shares outstanding was 151M at Jun 30, 2026. For fiscal 2023 it was 1M, down 80.3% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 1M | -80.3% |
| FY2022 | Dec 31, 2022 | 6M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 151M | +12841.2% |
| Q1 FY2026 | Mar 31, 2026 | 112M | +9490.8% |
| Q2 FY2025 | Jun 30, 2025 | 62M | +1398.1% |
| Q1 FY2025 | Mar 31, 2025 | 51M | +1128.5% |
| Q2 FY2024 | Jun 30, 2024 | 1M | -45.5% |
| Q1 FY2024 | Mar 31, 2024 | 1M | -35.1% |
| Q2 FY2023 | Jun 30, 2023 | 4M | +321.9% |
| Q1 FY2023 | Mar 31, 2023 | 4M | – |
| Q3 FY2019 | Sep 30, 2019 | 2M | – |
| Q2 FY2019 | Jun 30, 2019 | 2M | – |
| Q3 FY2018 | Sep 30, 2018 | 1M | – |
See a number that looks wrong?